Abstracts Archive - Page 387 of 1683 - ATC Abstracts

2020 American Transplant Congress
Can HLA-DQ Molecular Mismatch Analysis Be Used to Predict Generation of De Novo Donor-Specific Antibody at an Individual Patient Level?
D. Pinelli¹, M. Casillas Abundis¹, R. Hod Dvorai², H. McDowell¹, A. R. Tambur¹
¹Northwestern University, Chicago, IL, ²SUNY Upstate Medical University, Syracuse, NY
*Purpose: De novo donor-specific antibodies (dnDSA), especially to HLA-DQ, are one of the leading causes of late kidney graft failure. Many investigators have attempted to…
2020 American Transplant Congress
The 1st Year Posttransplant Course Reliably Predicts Kidney Graft Survival up to 15 Years Using a Machine Learning-Based Modeling Approach
W. Gwinner, M. Gietzelt, R. Hanna, A. A. Khalifa, M. Hallensleben, M. Marschollek, H. Haller, J. H. Braesen, I. Scheffner
Hannover Medical School, Hannover, Germany
*Purpose: Identification of patients at risk for graft failure can improve individual surveillance and early therapeutic interventions. We used a well-documented patient cohort to establish…
2020 American Transplant Congress
“By the Time They Get to Me, I’ll Be Dead Anyway” – A Mixed-Methods Examination of Treatment Education & Decision-Making among Patients with Varying Amounts of Pre-End-Stage Renal Disease Nephrology Care
M. Urbanski¹, L. Dumenci¹, C. Gadegbeku², L. Siminoff¹, A. Waterman³, H. Gardiner¹
¹College of Public Health, Temple University, Philadelphia, PA, ²Lewis Katz School of Medicine, Section of Nephrology, Hypertension, and Kidney Transplantation, Temple University, Philadelphia, PA, ³UCLA, Division of Nephrology, Los Angeles, CA
*Purpose: The aim of this study was to explore renal replacement therapy (RRT) knowledge and decision-making experiences and preferences among patients with varying amounts of…
2020 American Transplant Congress
Glomerular C4d in Post-Transplant IgA Glomerulonephritis is Associated with Decreased Allograft Survival
Z. Kikic, H. Omic, B. Perschl, G. Böhmig, N. Kozakowski, M. Eder
Medical University of Vienna, Vienna, Austria
*Purpose: Post transplant (pTX) glomerulonephritis (GN) is an important factor contributing to early and late allograft failure. De novo or recurrent IgA GN are the…
2020 American Transplant Congress
Living Donor Nephrectomy Outcomes in the Us: Analysis of HCUP Data
M. S. Gharibdousti¹, M. T. Khasawneh², A. L. Friedman³
¹Research, Live On NY, Brooklyn, NY, ²System Science and Industrial Engineering, Binghamton University, Binghamton, NY, ³Preservation, Live On NY, New York, NY
*Purpose: To identify clinical outcomes and complications of living donor nephrectomies in the US from 2008 - 2015.*Methods: A retrospective analysis of 2008-2015 discharge data…
2020 American Transplant Congress
Successful Transplantation Outcomes Utilizing Deceased Donorswith Acute Kidney Injury
A. Harshman, L. Preczewski, M. Muldoon, G. Guerra
Kidney and Kidney/Pancreas Transplant, Miami Transplant Institute, Miami, FL
*Purpose: Kidneys from deceased donors with acute kidney injury (AKI) are discarded at a higher rate than those without AKI, exacerbating the organ shortage crisis.…
2020 American Transplant Congress
De Novo Use of Envarsus (LCPT) in African American and Elderly Kidney Transplant Recipients: An Early Single Center Experience
N. Wilson¹, R. Leek¹, R. Forbes², D. Shaffer², S. Rega³, I. Feurer³, B. Concepcion⁴, A. Langone⁴
¹Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, ²Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, ³Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN, ⁴Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Clinical trials with LCPT have shown a steadier and more consistent concentration time profile over 24 hours with increased bioavailability compared to twice daily…
2020 American Transplant Congress
Efficacy and Possible Risk of De Novo Use of Everolimus for Primary Kidney Transplantation
S. Narumi¹, Y. Watarai¹, N. Goto², T. Hiramtsu¹, M. Okada¹, K. Futamura², T. Tomosugi¹, A. Kanda², T. Kobayashi³
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ²Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ³Transplant Surgery, Aichi Medical University School of Medicine, Nagakute City, Aichi Prefecture, Japan
*Purpose: Transplant outcome and protocol stay rate of everolimus were investigated to clarify efficacy and risk of everolimus based regimens at a single institute.*Methods: During…
2020 American Transplant Congress
Tacrolimus Concentrations Are Associated with Measures of Body Composition in Adult Kidney Transplant Recipients
K. S. Parker¹, B. Derstine², J. Sullivan², S. Wang², A. Mazurek¹, D. Cron¹, S. Waits¹
¹Department of Surgery, University of Michigan, Ann Arbor, MI, ²Morphomic Analysis Group, University of Michigan, Ann Arbor, MI
*Purpose: Tacrolimus (Tacro) is essential for kidney transplant immunosuppression but has a narrow therapeutic window. Tacro dosing preventing rejection must be balanced with potential delayed…
2020 American Transplant Congress
Improvement of Renal Function Prior to Liver Transplantation is Not Associated with Better Long-Term Renal Outcome or Mortality
M. Sterneck¹, T. Horvatits², M. Touma², U. Herden³, A. Lohse², L. Fischer³
¹University Medical Center Hamburg Eppendorf, Hamburg, Germany, ²Department of Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany, ³Transplant Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
*Purpose: Since introduction of the MELD score in the liver allocation system, renal impairment in OLT recipients has become a topic of increasing importance. This…